Announcements Trials
Browse Landscape

Phase

Phase 1/2 2Phase 1 1

Status

Not yet recruiting 3Recruiting 2Suspended 1

Sponsor Class

INDUSTRY 3

Study Type

Interventional 3

Sponsor

Cancer Type

Other solid neoplasm 3

Conditions

Breast Neoplasms 52Neoplasms 36Colorectal Neoplasms 33Prostatic Neoplasms 31Carcinoma, Non-Small-Cell Lung 31Lung Neoplasms 30Pancreatic Neoplasms 21Multiple Myeloma 16Recurrence 14Ovarian Neoplasms 14Uterine Cervical Neoplasms 12Leukemia, Myeloid, Acute 11Carcinoma, Hepatocellular 11Neoplasm Metastasis 10Head and Neck Neoplasms 10Brain Neoplasms 10Melanoma 9Stomach Neoplasms 8Squamous Cell Carcinoma of Head and Neck 8Rectal Neoplasms 8Advanced Solid Tumors 8Triple Negative Breast Neoplasms 7Small Cell Lung Carcinoma 7Glioblastoma 7Endometrial Neoplasms 7Carcinoma, Renal Cell 7Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Glioma 6Esophageal Neoplasms 6Colonic Neoplasms 6

Interventions

sintilimab 1osimertinib 1Carboplatin 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Not yet recruiting × Solid Tumor × 30 days × Clear all
NCT07623707 2026-06-03

A Study of FG-B901 Monotherapy or Combination With Chemotherapy in Advanced or Metastatic Solid Tumors

FutureGen Biopharmaceutical (Beijing) Co., Ltd

Phase 1/2 Not yet recruiting
264 enrolled
Other solid neoplasm

Solid Tumor

NCT07612137 2026-05-28

Study of IBI3005 Combination Therapy in Participants With Unresectable, Locally Advanced or Metastatic Solid Tumors

Innovent Biologics (Suzhou) Co. Ltd.

Phase 1/2 Not yet recruiting
282 enrolled
Other solid neoplasm

Solid Tumor

NCT07606612 2026-05-26

A Study of SI-B036 in Patients With Locally Advanced or Metastatic Solid Tumors

Sichuan Baili Pharmaceutical Co., Ltd.

Phase 1 Not yet recruiting
31 enrolled
Other solid neoplasm

Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡